Search results
Jump to navigation
Jump to search
Page title matches
- ...892294">{{cite journal |author=Guzé BH, Baxter LR |title=Current concepts. Neuroleptic malignant syndrome |journal=N. Engl. J. Med. |volume=313 |issue=3 |pages=163-6 |year=1985 |pmi ...to D, Ishigami T, Kosaka K |title=Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D(2) receptor gene |journal=Mo4 KB (460 words) - 06:00, 25 September 2024
- #Redirect [[Neuroleptic malignant syndrome]]44 bytes (4 words) - 18:07, 6 May 2008
- 187 bytes (24 words) - 03:34, 8 September 2009
- Auto-populated based on [[Special:WhatLinksHere/Neuroleptic malignant syndrome]]. Needs checking by a human.733 bytes (91 words) - 06:00, 25 September 2024
Page text matches
- #REDIRECT [[Neuroleptic malignant syndrome]]44 bytes (4 words) - 06:40, 2 April 2008
- #Redirect [[Neuroleptic malignant syndrome]]44 bytes (4 words) - 18:07, 6 May 2008
- {{r|Neuroleptic malignant syndrome}} {{r|Neuroleptic malignant syndrome}}724 bytes (89 words) - 11:00, 17 October 2024
- {{r|Neuroleptic malignant syndrome}} {{r|Neuroleptic malignant syndrome}}1 KB (135 words) - 06:00, 16 August 2024
- ...892294">{{cite journal |author=Guzé BH, Baxter LR |title=Current concepts. Neuroleptic malignant syndrome |journal=N. Engl. J. Med. |volume=313 |issue=3 |pages=163-6 |year=1985 |pmi ...to D, Ishigami T, Kosaka K |title=Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D(2) receptor gene |journal=Mo4 KB (460 words) - 06:00, 25 September 2024
- * [[Neuroleptic malignant syndrome]]1 KB (136 words) - 06:01, 15 September 2024
- Auto-populated based on [[Special:WhatLinksHere/Neuroleptic malignant syndrome]]. Needs checking by a human.733 bytes (91 words) - 06:00, 25 September 2024
- {{r|Neuroleptic malignant syndrome}}590 bytes (73 words) - 06:01, 15 September 2024
- ...e [[depression]]] produce hyperkinesia".<ref name="pmid15784664"/> Lastly, neuroleptic malignant syndrome may develop over several days while serotonin syndrome develops faster.4 KB (498 words) - 12:03, 17 October 2024
- {{r|Neuroleptic malignant syndrome}}582 bytes (67 words) - 11:00, 8 October 2024
- {{r|Neuroleptic malignant syndrome}}678 bytes (83 words) - 11:00, 28 July 2024
- ...to D, Ishigami T, Kosaka K |title=Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D(2) receptor gene |journal=Mo2 KB (304 words) - 06:50, 30 September 2009
- {{r|Neuroleptic malignant syndrome}}1 KB (175 words) - 11:00, 6 August 2024
- {{r|Neuroleptic malignant syndrome}}732 bytes (75 words) - 11:00, 11 July 2024
- ...a [[depression]]] produce hyperkinesia".<ref name="pmid15784664"/> Lastly, neuroleptic malignant syndrome may develop over several days while serotonin syndrome develops faster. ====Neuroleptic malignant syndrome====9 KB (1,252 words) - 06:00, 16 August 2024
- ===Neuroleptic malignant syndrome=== {{main|Neuroleptic malignant syndrome}}7 KB (877 words) - 11:00, 11 July 2024
- ...to D, Ishigami T, Kosaka K |title=Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D(2) receptor gene |journal=Mo ====Neuroleptic malignant syndrome====11 KB (1,479 words) - 11:01, 8 August 2024
- ...to D, Ishigami T, Kosaka K |title=Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D(2) receptor gene |journal=Mo12 KB (1,576 words) - 16:01, 18 July 2024
- **Non-immune reactions such as [[porphyria]], [[malignant hyperthermia]], [[neuroleptic malignant syndrome]], or [[malignant hyperthermia]]. As the mechanisms of these specific react39 KB (5,361 words) - 16:35, 10 February 2024
- *[[User:Robert Badgett|Bob]] dealt with some [[Neuroleptic malignant syndrome|syndromes]]25 KB (3,941 words) - 04:06, 8 March 2024